Antimicrobial Resistance (AMR) Awareness Week, running from 18 to 24 November, is a global campaign to raise awareness and understanding of AMR. New research at Wythenshawe Hospital, part of ...

A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with gentamicin, a commonly used antibiotic, is being trialled across 14 NHS neonatal (specialist ...

New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.

New research from the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) has shown the chance of being correctly diagnosed with asthma varies widely ...

Nursing, Midwifery and Allied Health Professionals (NMAHP) researchers at Manchester University NHS Foundation Trust (MFT), in partnership with The University of Manchester (UoM) are leading UK-first ...

A woman in Manchester is the first person in the UK to receive an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, ...

On Tuesday 10 September 2024, MFT's Innovation Team brought together colleagues from across the NHS, academia and industry to showcase our innovation offer at MFT.

Children with Ewing sarcoma, a rare type of cancer in the bone, or surrounding tissues, are part of pioneering research being delivered in Manchester, that could transform treatment, to improve ...